AstraZeneca to acquire EsoBiotec
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system…
Imfinzi has been approved in the EU as monotherapy for the treatment of adults with limited-stage SCLC
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed following platinum-based chemoradiation therapy (CRT). The approval by the European Commission follows…
FDA has approved TNKase® for the treatment of acute ischemic stroke in adults
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS) in adults. This approval of TNKase…
ELAHERE® Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients
AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant…
Positive topline results from the Phase 3 VERITAC-2 clinical trial
Arvinas and Pfizer today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant in adults with estrogen receptor-positive, human epidermal growth factor…
Servier is awarded the Gallup Exceptional Workplace Award for the second consecutive year
This year again, Servier is honored with the Gallup Exceptional Workplace Award. This distinction highlights organizations that integrate employee engagement at the heart of their strategy and corporate culture. While receiving this award last year was a major recognition, obtaining…
Merck Unveils New Facility to Increase Vaccine Production Capacity
Merck, known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a…
GSK set to achieve 100% renewable electricity at all manufacturing sites in Singapore from 2025
GSK has today announced it has signed a 10-year energy deal with Sembcorp Industries Ltd, covering the electricity demand for all three of GSK’s global manufacturing sites in Singapore. This…
Roche expands access to cervical cancer screening tools with two new WHO prequalification designations
Roche announced today that the World Health Organization (WHO) has awarded the cobas® HPV test prequalification designations for use on the cobas® 5800 system and for self-collected samples on the cobas®…
AstraZeneca to acquire EsoBiotec
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and…
Ami Polymer provides innovative polymer solutions for affordable healthcare
Could you share some significant milestones from your career? With over 25 years at the helm as Managing Director of Ami Polymer Pvt. Ltd. (APPL), me and my dynamic team have led the company to international prominence as a key player…